SCHEMBL5528853

SCHEMBL5528853

C=C[C@@H]1C[C@]1(NC(=O)OC(C)(C)C)C(=O)NS(=O)(=O)c1ccccc1NC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1013596 0.90 — —
SCHEMBL13223274 0.85 — —
SCHEMBL1014669 0.85 — —
SCHEMBL8261915 0.83 TET3 (0.39) —
SCHEMBL8270883 0.83 TET3 (0.39) —
SCHEMBL13245776 0.83 — —
SCHEMBL3058114 0.83 METAP2 (0.41) —
SCHEMBL3044103 0.83 CYP3A4 (0.33) —
SCHEMBL1014453 0.82 METAP2 (0.33) —
SCHEMBL2807102 0.81 PTPRC (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070265281-A1 Organic Compounds and Their Uses COTTENS SYLVAIN 2007-11-15 — — US disclosed
US-20070265281-A1 Organic Compounds and Their Uses COTTENS SYLVAIN 2007-11-15 — — US disclosed
US-20070265281-A1 Organic Compounds and Their Uses COTTENS SYLVAIN 2007-11-15 — — US disclosed
WO-2007121125-A2 HCV INHIBITORS NOVARTIS AG (CH) 2007-10-25 — — WO disclosed
Send feedback